Double Outlet Right Ventricle (DORV) Repair — Cost, Top Hospitals & Success Rates | MyMedicPlus

Double outlet right ventricle (DORV) is a complex congenital cardiac anomaly in which both the aorta and the pulmonary artery arise predominantly or exclusively from the morphological right ventricle, with a ventricular septal defect (VSD) serving as the only outlet for the left ventricle. DORV encompasses a spectrum of anatomical variants — the specific anatomy (particularly the relationship of the VSD to the great arteries, the presence and type of subpulmonary or subaortic obstruction, and the relationship of the great arteries to each other) determines the appropriate surgical strategy and overall complexity of repair.

DORV accounts for approximately 1% of all congenital heart defects. The physiological consequences range from a presentation resembling a simple large VSD (when the VSD is subaortic and the great arteries are normally related — 'DORV, subaortic VSD') to presentations resembling tetralogy of Fallot (VSD with pulmonary stenosis — 'DORV, Fallot type') or transposition of the great arteries (when the aorta is to the right of and anterior to the pulmonary artery — 'DORV with transposition physiology' or the Taussig-Bing anomaly).

Surgical repair of DORV requires cardiopulmonary bypass, moderate hypothermia (typically 28–32°C), cardioplegic myocardial arrest, and intraoperative echocardiographic confirmation of repair adequacy. The fundamental goal in all DORV repairs is to establish unobstructed blood flow from the left ventricle (via the VSD) to the aorta — achieving 'biventricular repair' — while maintaining unobstructed pulmonary blood flow and avoiding injury to the cardiac conduction system. The surgical techniques employed vary significantly based on the specific anatomical subtype and include intraventricular tunnel repair, arterial switch operation with VSD closure, and staged palliation followed by complete repair.

DORV with subaortic VSD (VSD beneath the aortic valve) — the most common subtype (approximately 50%) — has VSD-to-aorta alignment, with both great arteries typically in normal (right-left) relationship. Surgical repair creates an intraventricular tunnel (baffle) directing left ventricular blood through the VSD to the aorta. When pulmonary stenosis coexists (DORV Fallot-type), the right ventricular outflow tract obstruction reduces pulmonary blood flow, producing cyanosis — repair involves patch closure with intraventricular tunnel repair plus right ventricular outflow tract reconstruction.

DORV with subpulmonary VSD (VSD beneath the pulmonary valve — Taussig-Bing anomaly) has the great arteries transposed (aorta anterior-rightward of pulmonary artery) — physiologically resembling transposition of the great arteries. The surgical approach is arterial switch operation (translocating the aorta and pulmonary artery to their correct ventricular origins) combined with VSD closure — a more complex procedure than isolated subaortic DORV repair. DORV with non-committed VSD (VSD remote from either great artery — doubly committed or inlet VSD) presents the greatest surgical challenge, as construction of an intraventricular tunnel long enough to direct LV blood to the aorta without obstruction may not be feasible, and alternative strategies (including univentricular palliation) may be required.

All infants with DORV require surgical repair — the condition is not compatible with long-term survival without definitive intervention. The timing and approach depend on the haemodynamic severity of presentation. Infants with Taussig-Bing anomaly (DORV with subpulmonary VSD and transposition physiology) present early in life with severe cyanosis and congestive heart failure, requiring early surgical repair at 1–2 months of age after initial stabilisation and balloon atrial septostomy if needed.

Infants with DORV with subaortic VSD without pulmonary stenosis present with signs of large left-to-right shunt (heart failure, failure to thrive, recurrent chest infections) — surgery is performed at 3–6 months before pulmonary vascular disease develops. DORV Fallot-type presents with cyanosis of variable severity depending on the degree of pulmonary stenosis — management follows principles similar to tetralogy of Fallot repair, performed electively at 3–6 months. Pre-operative cardiac catheterisation and angiography (or detailed cardiac MRI) are essential in all cases for precise delineation of anatomy prior to surgical planning. Genetic evaluation for associated syndromes (DORV occurs with increased frequency in trisomy 18, trisomy 13, DiGeorge syndrome, and CHARGE syndrome) is recommended to inform overall prognosis and management.

Intraventricular tunnel repair (Kawashima repair) — the most common approach for subaortic DORV — constructs a pericardial or synthetic patch baffle within the right ventricle, routing the VSD outlet to the aorta through a tunnel. The tunnel must be of adequate width to avoid left ventricular outflow tract obstruction (LVOTO — a significant cause of re-operation), must not compress the right ventricular cavity, and must not impinge on the tricuspid valve apparatus or conduction system. Intraoperative echocardiography guides the repair and confirms adequate tunnel geometry and freedom from LVOTO before chest closure.

Arterial switch operation with VSD closure is performed for Taussig-Bing anomaly — the same operation as for D-transposition of the great arteries (transecting both great arteries above the semilunar valves and anastomosing the aorta to the native pulmonary root over the left ventricle, and the pulmonary artery to the native aortic root over the right ventricle), with the addition of VSD patch closure. Coronary artery transfer is performed with meticulous care to avoid coronary kinking or tension — the most important determinant of early mortality.

Staged palliation — initial pulmonary arterial banding for DORV with large left-to-right shunt and non-committed VSD to limit pulmonary blood flow and allow time for surgical planning — followed by complete repair at 6–12 months, or modified Fontan palliation if biventricular repair is not feasible. Some complex DORV anatomies (remote non-committed VSD, associated atrioventricular septal defect, or severely hypoplastic left ventricle) may be directed toward univentricular palliation (Norwood-Fontan pathway) rather than biventricular repair.

Outcomes for DORV repair depend significantly on anatomical subtype, timing of surgery, and the technical complexity of the specific repair. For straightforward DORV with subaortic VSD repaired via intraventricular tunnel at experienced centres, early mortality rates are 1–5% with 10-year survival exceeding 90%. Freedom from re-operation at 10 years is approximately 75–85% — the most common reinterventions being relief of residual LVOTO, pulmonary artery reconstruction, and VSD patch revision.

For Taussig-Bing anomaly repaired by arterial switch plus VSD closure at high-volume congenital heart centres, early mortality rates are 3–8% with 10-year survival of 80–90%. Long-term neopulmonary artery stenosis (supravalvar or branch) requiring catheter-based balloon dilation or surgical repair occurs in 10–30% over 10 years, similar to arterial switch for simple transposition. At experienced centres of excellence — such as those in India (All India Institute of Medical Sciences, Kokilaben Hospital, Apollo Hospitals), Singapore, Thailand, and Turkey — outcomes are competitive with leading Western centres, at dramatically lower cost.

DORV repair carries the general risks of open heart surgery on cardiopulmonary bypass: bleeding requiring re-exploration (3–5%), arrhythmias (including complete heart block requiring permanent pacemaker implantation — 1–2%), stroke or neurological injury, renal failure, pulmonary complications, and wound infection. Specific to DORV repair, residual or recurrent left ventricular outflow tract obstruction (caused by tunnel baffle creating subaortic narrowing) is the most important long-term complication, occurring in 10–20% at 10 years and often requiring surgical revision.

For arterial switch-based repairs (Taussig-Bing), coronary artery complications (including coronary ostial stenosis, kinking, or spasm) are the most critical perioperative risks — causing myocardial ischaemia or low cardiac output after cardiopulmonary bypass. Meticulous coronary transfer technique and careful assessment of coronary anatomy on pre-operative imaging reduce but do not eliminate this risk. Pulmonary artery stenosis (at the anastomotic site or at branch points) requiring catheter balloon dilation or surgical patch augmentation is a predictable long-term complication in 20–30% of patients.

Lifelong cardiology follow-up is mandatory for all patients with repaired DORV. Initial post-operative follow-up at 6 weeks, 3 months, and 6 months assesses ventricular function, residual shunts, outflow tract gradients, and arrhythmias. Annual cardiac MRI and echocardiography monitor for the development of LVOTO, right ventricular dilation, pulmonary artery stenosis, and ventricular dysfunction over time.

Most patients with successfully repaired DORV lead normal or near-normal lives in childhood and adulthood. Exercise restrictions during childhood are guided by the residual haemodynamics; most patients with well-repaired DORV can participate in moderate physical activity. Patients with residual LVOTO or right heart enlargement require ongoing activity restriction guidance from their cardiologist. All women of childbearing age with repaired DORV should receive pre-conception cardiology counselling — pregnancy carries increased haemodynamic demand and risk stratification is required. Transfer from paediatric to adult congenital heart disease (ACHD) services at adolescence ensures continuity of specialist follow-up through adulthood.

DORV surgical repair in the United States typically costs $100,000–$300,000 or more, depending on operative complexity, ICU duration, and length of hospitalisation. In the UK under the NHS, the procedure is available for British citizens, but non-residents face substantial costs. These procedures are performed only at specialised paediatric cardiac surgery centres.

For families from countries without access to paediatric cardiac surgery, medical tourism to specialist cardiac centres in India, Thailand, Singapore, or Turkey offers life-saving surgery at radically lower cost. In India, DORV repair at JCI-accredited centres (Fortis Escorts Heart Institute, Apollo Children's Hospital, Narayana Health) costs USD 8,000–20,000 for the complete surgical package — including pre-operative workup, surgery, ICU care, and initial follow-up. Thailand and Singapore offer similar procedures at USD 15,000–35,000. These centres perform hundreds of congenital heart operations annually and publish outcomes competitive with major Western paediatric cardiac centres. Many cardiac surgery missions and charitable organisations also provide subsidised or free congenital heart surgery for children from low-income countries at select Indian and Thai centres.

For DORV anatomies where biventricular repair is not feasible — primarily due to a remote non-committed VSD, associated hypoplastic left ventricle, or unbalanced atrioventricular canal defect — staged univentricular palliation (single ventricle Fontan pathway) is pursued. The Fontan palliation involves staging the circulation so that systemic venous blood bypasses the right ventricle entirely and flows passively to the pulmonary arteries: Stage 1 (neonatal palliation — modified Blalock-Taussig shunt or Norwood procedure depending on anatomy); Stage 2 (bidirectional Glenn at 4–6 months); Stage 3 (Fontan completion at 2–4 years).

The Fontan circulation is not equivalent to a normal two-ventricle circulation — long-term complications including Fontan-associated liver disease, protein-losing enteropathy, plastic bronchitis, and atrial arrhythmias necessitate lifelong intensive follow-up. Fontan palliation enables survival to adulthood but with significant long-term morbidity. For this reason, every effort is made to achieve biventricular repair in DORV, reserving the Fontan pathway for anatomies where biventricular repair would create residual haemodynamic compromise greater than the Fontan pathway itself.